Cargando...

Response to “Letter to the editor on the paper: The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing”

Gardado en:
Detalles Bibliográficos
Publicado en:Mult Scler
Main Authors: van Kempen, Zoé LE, Rispens, Theo, Killestein, Joep
Formato: Artigo
Idioma:Inglês
Publicado: SAGE Publications 2017
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5971362/
https://ncbi.nlm.nih.gov/pubmed/28990853
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1352458517734073
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!